{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:11:52Z","timestamp":1793142712684,"version":"4.5.0"},"reference-count":149,"publisher":"Elsevier","isbn-type":[{"value":"9780323997867","type":"print"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/bs.pmbts.2022.06.031","type":"book-chapter","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T20:51:01Z","timestamp":1658523061000},"page":"153-174","source":"Crossref","is-referenced-by-count":34,"title":["Gut dysbiosis and metabolic diseases"],"prefix":"10.1016","author":[{"given":"Purbita","family":"Bandopadhyay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipyaman","family":"Ganguly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/bs.pmbts.2022.06.031_bb0010","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The human intestinal microbiome in health and disease","volume":"375","author":"Lynch","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/bs.pmbts.2022.06.031_bb0015","doi-asserted-by":"crossref","first-page":"19417","DOI":"10.1038\/s41598-020-76474-8","article-title":"Gut microbiota and metabolic health among overweight and obese individuals","volume":"10","author":"Kim","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.031_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1897212","article-title":"The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health","volume":"13","author":"Nogal","year":"2021","journal-title":"Gut Microbes"},{"key":"10.1016\/bs.pmbts.2022.06.031_bb0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","article-title":"Gut microbiota in human metabolic health and disease","volume":"19","author":"Fan","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/bs.pmbts.2022.06.031_bb0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature11450","article-title":"A metagenome-wide association study of gut microbiota in type 2 diabetes","volume":"490","author":"Qin","year":"2012","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2022.06.031_bb0035","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","article-title":"The role of the gut microbiota in NAFLD","volume":"13","author":"Leung","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/bs.pmbts.2022.06.031_bb0040","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1161\/HYPERTENSIONAHA.115.05315","article-title":"Gut dysbiosis is linked to hypertension","volume":"65","author":"Yang","year":"2015","journal-title":"Hypertension"},{"issue":"7285","key":"10.1016\/bs.pmbts.2022.06.031_bb0045","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature08821","article-title":"A human gut microbial gene catalogue established by metagenomic sequencing","volume":"464","author":"Qin","year":"2010","journal-title":"Nature"},{"issue":"8","key":"10.1016\/bs.pmbts.2022.06.031_bb0050","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nbt.2942","article-title":"An integrated catalog of reference genes in the human gut microbiome","volume":"32","author":"Li","year":"2014","journal-title":"Nat Biotechnol"},{"issue":"7","key":"10.1016\/bs.pmbts.2022.06.031_bb0055","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/bs.pmbts.2022.06.031_bb0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00125-009-1573-7","article-title":"The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation","volume":"53","author":"Kolb","year":"2010","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/bs.pmbts.2022.06.031_bb0065","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.2337\/db07-1403","article-title":"Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice","volume":"57","author":"Cani","year":"2008","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/bs.pmbts.2022.06.031_bb0070","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S2468-1253(21)00143-6","article-title":"Obesity: Another ongoing pandemic","volume":"6","author":"The Lancet Gastroenterology Hepatology","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/bs.pmbts.2022.06.031_bb0075","first-page":"276","article-title":"Epidemiology of obesity in adults: Latest trends","volume":"7","author":"Inoue","year":"2018","journal-title":"CurrObes Rep"},{"issue":"2","key":"10.1016\/bs.pmbts.2022.06.031_bb0080","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/19490976.2016.1270811","article-title":"Western diets, gut dysbiosis, and metabolic diseases: Are they linked?","volume":"8","author":"Martinez","year":"2017","journal-title":"Gut Microbes"},{"issue":"10","key":"10.1016\/bs.pmbts.2022.06.031_bb0085","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1161\/CIRCULATIONAHA.111.067264","article-title":"Body fat distribution and risk of cardiovascular disease: An update","volume":"126","author":"Despr\u00e9s","year":"2012","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/bs.pmbts.2022.06.031_bb0090","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archinte.165.7.777","article-title":"Obesity, regional body fat distribution, and the metabolic syndrome in older men and women","volume":"165","author":"Goodpaster","year":"2005","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1016\/bs.pmbts.2022.06.031_bb0095","first-page":"4948","article-title":"Germ-free C57BL\/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism","volume":"24","author":"Rabot","year":"2010","journal-title":"FASEB J"},{"issue":"6150","key":"10.1016\/bs.pmbts.2022.06.031_bb0100","doi-asserted-by":"crossref","first-page":"1241214","DOI":"10.1126\/science.1241214","article-title":"Gut microbiota from twins discordant for obesity modulate metabolism in mice","volume":"341","author":"Ridaura","year":"2013","journal-title":"Science"},{"issue":"4","key":"10.1016\/bs.pmbts.2022.06.031_bb0105","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cmet.2017.09.008","article-title":"Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition","volume":"26","author":"Kootte","year":"2017","journal-title":"Cell Metab"},{"issue":"4","key":"10.1016\/bs.pmbts.2022.06.031_bb0110","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","article-title":"Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome","volume":"143","author":"Vrieze","year":"2012","journal-title":"Gastroenterology"},{"issue":"9491","key":"10.1016\/bs.pmbts.2022.06.031_bb0115","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"IDF epidemiology task force consensus group. The metabolic syndrome--a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/bs.pmbts.2022.06.031_bb0120","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1210\/er.2008-0024","article-title":"The metabolic syndrome","volume":"29","author":"Cornier","year":"2008","journal-title":"Endocr Rev"},{"issue":"9710","key":"10.1016\/bs.pmbts.2022.06.031_bb0125","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0140-6736(09)61794-3","article-title":"The metabolic syndrome","volume":"375","author":"Eckel","year":"2010","journal-title":"Lancet"},{"issue":"7484","key":"10.1016\/bs.pmbts.2022.06.031_bb0130","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature12820","article-title":"Diet rapidly and reproducibly alters the human gut microbiome","volume":"505","author":"David","year":"2014","journal-title":"Nature"},{"issue":"8","key":"10.1016\/bs.pmbts.2022.06.031_bb0135","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1136\/gutjnl-2018-317609","article-title":"Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors: A 6-month randomised controlled-feeding trial","volume":"68","author":"Wan","year":"2019","journal-title":"Gut"},{"issue":"7585","key":"10.1016\/bs.pmbts.2022.06.031_bb0140","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nature16504","article-title":"Diet-induced extinctions in the gut microbiota compound over generations","volume":"529","author":"Sonnenburg","year":"2016","journal-title":"Nature"},{"issue":"5","key":"10.1016\/bs.pmbts.2022.06.031_bb0145","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.cell.2016.10.043","article-title":"A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility","volume":"167","author":"Desai","year":"2016","journal-title":"Cell"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.031_bb0150","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1038\/s41467-021-22097-0","article-title":"Fasting alters the gut microbiome reducing blood pressure and body weight in metabolic syndrome patients","volume":"12","author":"Maifeld","year":"2021","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/bs.pmbts.2022.06.031_bb0155","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.cmet.2017.08.019","article-title":"Intermittent fasting promotes white adipose Browning and Decreases obesity by shaping the gut microbiota","volume":"26","author":"Li","year":"2017","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.031_bb0160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.chom.2017.11.003","article-title":"Fiber-mediated nourishment of gut microbiota protects against diet-induced obesity by restoring IL-22-mediated colonic health","volume":"23","author":"Zou","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"6","key":"10.1016\/bs.pmbts.2022.06.031_bb0165","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.cell.2020.04.027","article-title":"Ketogenic diets Alter the gut microbiome resulting in decreased intestinal Th17 cells","volume":"181","author":"Ang","year":"2020","journal-title":"Cell"},{"issue":"7","key":"10.1016\/bs.pmbts.2022.06.031_bb0170","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41591-019-0495-2","article-title":"Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: A proof-of-concept exploratory study","volume":"25","author":"Depommier","year":"2019","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/bs.pmbts.2022.06.031_bb0175","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3389\/fgene.2019.01329","article-title":"The epigenetic connection between the gut microbiome in obesity and diabetes","volume":"15","author":"Sharma","year":"2020","journal-title":"Front Genet"},{"issue":"7","key":"10.1016\/bs.pmbts.2022.06.031_bb0180","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.celrep.2017.01.062","article-title":"Host genotype and gut microbiome modulate insulin secretion and diet-induced metabolic phenotypes","volume":"18","author":"Kreznar","year":"2017","journal-title":"Cell Rep"},{"issue":"11","key":"10.1016\/bs.pmbts.2022.06.031_bb0185","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1016\/j.celrep.2018.02.060","article-title":"Diet, genetics, and the gut microbiome drive dynamic changes in plasma metabolites","volume":"22","author":"Fujisaka","year":"2018","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/bs.pmbts.2022.06.031_bb0190","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cmet.2015.07.007","article-title":"Interactions between gut microbiota, host genetics and diet modulate the predisposition to obesity and metabolic syndrome","volume":"22","author":"Ussar","year":"2015","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.031_bb0195","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cmet.2012.12.007","article-title":"Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice","volume":"17","author":"Parks","year":"2013","journal-title":"Cell Metab"},{"issue":"16","key":"10.1016\/bs.pmbts.2022.06.031_bb0200","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.cub.2013.06.039","article-title":"Entrainment of the human circadian clock to the natural light-dark cycle","volume":"23","author":"Wright","year":"2013","journal-title":"Curr Biol"},{"issue":"4","key":"10.1016\/bs.pmbts.2022.06.031_bb0205","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cell.2013.04.020","article-title":"Homeostasis in intestinal epithelium is orchestrated by the circadian clock and microbiota cues transduced by TLRs","volume":"153","author":"Mukherji","year":"2013","journal-title":"Cell"},{"issue":"6","key":"10.1016\/bs.pmbts.2022.06.031_bb0210","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.cmet.2014.11.008","article-title":"Diet and feeding pattern affect the diurnal dynamics of the gut microbiome","volume":"20","author":"Zarrinpar","year":"2014","journal-title":"Cell Metab"},{"issue":"5","key":"10.1016\/bs.pmbts.2022.06.031_bb0215","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.chom.2015.03.006","article-title":"Effects of diurnal variation of gut microbes and high-fat feeding on host circadian clock function and metabolism","volume":"17","author":"Leone","year":"2015","journal-title":"Cell Host Microbe"},{"issue":"6","key":"10.1016\/bs.pmbts.2022.06.031_bb0220","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.cell.2016.11.003","article-title":"Microbiota diurnal rhythmicity programs host transcriptome oscillations","volume":"167","author":"Thaiss","year":"2016","journal-title":"Cell"},{"issue":"3","key":"10.1016\/bs.pmbts.2022.06.031_bb0225","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.cell.2014.09.048","article-title":"Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis","volume":"159","author":"Thaiss","year":"2014","journal-title":"Cell"},{"issue":"2","key":"10.1016\/bs.pmbts.2022.06.031_bb0230","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.chom.2020.06.004","article-title":"Arrhythmic gut microbiome signatures predict risk of type 2 diabetes","volume":"28","author":"Reitmeier","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"4","key":"10.1016\/bs.pmbts.2022.06.031_bb0235","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.cmet.2016.03.007","article-title":"The small molecule nobiletin targets the molecular oscillator to enhance circadian rhythms and protect against metabolic syndrome","volume":"23","author":"He","year":"2016","journal-title":"Cell Metab"},{"issue":"4","key":"10.1016\/bs.pmbts.2022.06.031_bb0240","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.cmet.2015.03.001","article-title":"Regulation of obesity-related insulin resistance with gut anti-inflammatory agents","volume":"21","author":"Luck","year":"2015","journal-title":"Cell Metab"},{"issue":"10","key":"10.1016\/bs.pmbts.2022.06.031_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047713","article-title":"High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/bs.pmbts.2022.06.031_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012191","article-title":"High-fat diet: Bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse","volume":"5","author":"Ding","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/bs.pmbts.2022.06.031_bb0255","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3892\/etm.2013.1214","article-title":"Expression and activity of the TLR4\/NF-\u03baB signaling pathway in mouse intestine following administration of a short-term high-fat diet","volume":"6","author":"Wang","year":"2013","journal-title":"Exp Ther Med"},{"issue":"12","key":"10.1016\/bs.pmbts.2022.06.031_bb0260","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.metabol.2008.07.029","article-title":"Intestinal, adipose, and liver inflammation in diet-induced obese mice","volume":"57","author":"Li","year":"2008","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/bs.pmbts.2022.06.031_bb0265","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cgh.2018.08.065","article-title":"Emerging role of the gut microbiome in nonalcoholic fatty liver disease: From composition to function","volume":"17","author":"Sharpton","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/bs.pmbts.2022.06.031_bb0270","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809302","article-title":"The role of the microbiome in NAFLD and NASH","volume":"11","author":"Kolodziejczyk","year":"2019","journal-title":"EMBO Mol Med"},{"issue":"12","key":"10.1016\/bs.pmbts.2022.06.031_bb0275","doi-asserted-by":"crossref","first-page":"G900","DOI":"10.1152\/ajpgi.00265.2013","article-title":"Gut-derived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids","volume":"305","author":"den Besten","year":"2013","journal-title":"Am J PhysiolGastrointest Liver Physiol"},{"issue":"5","key":"10.1016\/bs.pmbts.2022.06.031_bb0280","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: Disentangling microbial signatures from metabolic disorders","volume":"17","author":"Aron-Wisnewsky","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/bs.pmbts.2022.06.031_bb0285","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2337\/db11-1019","article-title":"Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2","volume":"61","author":"Tolhurst","year":"2012","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/bs.pmbts.2022.06.031_bb0290","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ijo.2014.153","article-title":"The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents","volume":"39","author":"Psichas","year":"2015","journal-title":"Int J Obes (Lond)"},{"issue":"1\u20132","key":"10.1016\/bs.pmbts.2022.06.031_bb0295","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cell.2013.12.016","article-title":"Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits","volume":"156","author":"De Vadder","year":"2014","journal-title":"Cell"},{"issue":"7606","key":"10.1016\/bs.pmbts.2022.06.031_bb0300","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nature18309","article-title":"Acetate mediates a microbiome-brain-\u03b2-cell axis to promote metabolic syndrome","volume":"534","author":"Perry","year":"2016","journal-title":"Nature"},{"issue":"8","key":"10.1016\/bs.pmbts.2022.06.031_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109163","article-title":"The gut microbiota regulates hypothalamic inflammation and leptin sensitivity in Western diet-fed mice via a GLP-1R-dependent mechanism","volume":"35","author":"Heiss","year":"2021","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.031_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00535-016-1242-9","article-title":"Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases","volume":"52","author":"Sun","year":"2017","journal-title":"J Gastroenterol"},{"issue":"7268","key":"10.1016\/bs.pmbts.2022.06.031_bb0315","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/nature08530","article-title":"Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43","volume":"461","author":"Maslowski","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.031_bb0320","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4049\/jimmunol.1501175","article-title":"Progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis is marked by a higher frequency of Th17 cells in the liver and an increased Th17\/resting regulatory T cell ratio in peripheral blood and in the liver","volume":"196","author":"Rau","year":"2016","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/bs.pmbts.2022.06.031_bb0325","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.2337\/dc13-0451","article-title":"Plasma lipopolysaccharide is closely associated with glycemic control and abdominal obesity: Evidence from bariatric surgery","volume":"36","author":"Tr\u00f8seid","year":"2013","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/bs.pmbts.2022.06.031_bb0330","doi-asserted-by":"crossref","first-page":"E740","DOI":"10.1152\/ajpendo.00302.2006","article-title":"Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes","volume":"292","author":"Creely","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"10.1016\/bs.pmbts.2022.06.031_bb0335","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/hep.29892","article-title":"Genetics of NAFLD in twins consortium. Link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD","volume":"68","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"issue":"33","key":"10.1016\/bs.pmbts.2022.06.031_bb0340","doi-asserted-by":"crossref","first-page":"12511","DOI":"10.1073\/pnas.0601056103","article-title":"Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice","volume":"103","author":"Dumas","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7341","key":"10.1016\/bs.pmbts.2022.06.031_bb0345","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"issue":"17","key":"10.1016\/bs.pmbts.2022.06.031_bb0350","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk","volume":"368","author":"Tang","year":"2013","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/bs.pmbts.2022.06.031_bb0355","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.031_bb0360","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism","volume":"24","author":"Wahlstr\u00f6m","year":"2016","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/bs.pmbts.2022.06.031_bb0365","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11892-011-0187-x","article-title":"Bile acid metabolism and the pathogenesis of type 2 diabetes","volume":"11","author":"Prawitt","year":"2011","journal-title":"Curr Diab Rep"},{"issue":"3","key":"10.1016\/bs.pmbts.2022.06.031_bb0370","first-page":"332","article-title":"Bile acids and the gut microbiome","volume":"30","author":"Ridlon","year":"2014","journal-title":"CurrOpin Gastroenterol"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.031_bb0375","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.livres.2017.05.001","article-title":"Bile acid metabolism and signaling in liver disease and therapy","volume":"1","author":"Chiang","year":"2017","journal-title":"Liver Res"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.031_bb0380","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/hep.28709","article-title":"Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives","volume":"65","author":"Arab","year":"2017","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/bs.pmbts.2022.06.031_bb0385","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jhep.2013.01.003","article-title":"Modulation of the fecal bile acid profile by gut microbiota in cirrhosis","volume":"58","author":"Kakiyama","year":"2013","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/bs.pmbts.2022.06.031_bb0390","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","article-title":"Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease","volume":"152","author":"Ch\u00e1vez-Talavera","year":"2017","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.031_bb0395","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/jdi.12687","article-title":"Role of gut microbiota, bile acids and their cross-talk in the effects of bariatric surgery on obesity and type 2 diabetes","volume":"9","author":"Liu","year":"2018","journal-title":"J Diabetes Investig"},{"issue":"6","key":"10.1016\/bs.pmbts.2022.06.031_bb0400","doi-asserted-by":"crossref","first-page":"19076","DOI":"10.1038\/srep19076","article-title":"Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults","volume":"8","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.031_bb0405","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.celrep.2018.12.028","article-title":"Parabacteroides distasonis alleviates obesity and metabolic dysfunctions via production of succinate and secondary bile acids","volume":"26","author":"Wang","year":"2019","journal-title":"Cell Rep"},{"issue":"5","key":"10.1016\/bs.pmbts.2022.06.031_bb0410","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.cmet.2018.07.001","article-title":"Impaired aryl hydrocarbon receptor ligand production by the gut microbiota is a key factor in metabolic syndrome","volume":"28","author":"Natividad","year":"2018","journal-title":"Cell Metab"},{"issue":"4","key":"10.1016\/bs.pmbts.2022.06.031_bb0415","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.celrep.2018.03.109","article-title":"Gut microbiota-derived tryptophan metabolites modulate inflammatory response in hepatocytes and macrophages","volume":"23","author":"Krishnan","year":"2018","journal-title":"Cell Rep"},{"issue":"351","key":"10.1016\/bs.pmbts.2022.06.031_bb0420","article-title":"Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: Systematic review and meta-analysis of observational studies","volume":"11","author":"de Souza","year":"2015","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/bs.pmbts.2022.06.031_bb0425","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2337\/diacare.28.7.1769","article-title":"Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: A summary of the evidence","volume":"28","author":"Ford","year":"2005","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/bs.pmbts.2022.06.031_bb0430","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4239\/wjd.v6.i4.613","article-title":"Lean diabetes mellitus: An emerging entity in the era of obesity","volume":"6","author":"George","year":"2015","journal-title":"World J Diabetes"},{"issue":"8","key":"10.1016\/bs.pmbts.2022.06.031_bb0435","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fphys.2017.00262","article-title":"Sedentary patterns, physical activity, and cardiorespiratory fitness in association to glycemic control in type 2 diabetes patients","volume":"28","author":"Sardinha","year":"2017","journal-title":"Front Physiol"},{"issue":"5","key":"10.1016\/bs.pmbts.2022.06.031_bb0440","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10654-017-0246-y","article-title":"Food groups and risk of type 2 diabetes mellitus: A systematic review and meta-analysis of prospective studies","volume":"32","author":"Schwingshackl","year":"2017","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"10.1016\/bs.pmbts.2022.06.031_bb0445","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.chom.2019.07.004","article-title":"Boehm RObese individuals with and without type 2 diabetes show different gut microbial functional capacity and composition","volume":"26","author":"Thingholm","year":"2019","journal-title":"Cell Host Microbe"},{"issue":"3","key":"10.1016\/bs.pmbts.2022.06.031_bb0450","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cmet.2020.06.011","article-title":"The gut microbiota in prediabetes and diabetes: A population-based cross-sectional study","volume":"32","author":"Wu","year":"2020","journal-title":"Cell Metab"},{"issue":"7758","key":"10.1016\/bs.pmbts.2022.06.031_bb0455","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41586-019-1236-x","article-title":"Longitudinal multi-omics of host-microbe dynamics in prediabetes","volume":"569","author":"Zhou","year":"2019","journal-title":"Nature"},{"issue":"4","key":"10.1016\/bs.pmbts.2022.06.031_bb0460","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.cell.2014.05.052","article-title":"Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences","volume":"158","author":"Cox","year":"2014","journal-title":"Cell"},{"issue":"8","key":"10.1016\/bs.pmbts.2022.06.031_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102900","article-title":"Gut dsDNA virome shows diversity and richness alterations associated with childhood obesity and metabolic syndrome","volume":"24","author":"Bikel","year":"2021","journal-title":"iScience"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.031_bb0470","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cmet.2015.06.001","article-title":"The gut microbiota regulates intestinal CD4 T cells expressing ROR\u03b3t and controls metabolic disease","volume":"22","author":"Garidou","year":"2015","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.031_bb0475","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-021-21408-9","article-title":"Lysates of Methylococcuscapsulatus Bath induce a lean-like microbiota, intestinal FoxP3+ROR\u03b3t+IL-17+ Tregs and improve metabolism","volume":"12","author":"Jensen","year":"2021","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/bs.pmbts.2022.06.031_bb0480","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.cmet.2018.08.005","article-title":"Functional gut microbiota remodeling contributes to the caloric restriction-induced metabolic improvements","volume":"28","author":"Fabbiano","year":"2018","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.031_bb0485","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cmet.2019.11.001","article-title":"Gut microbiome fermentation determines the efficacy of exercise for diabetes prevention","volume":"31","author":"Liu","year":"2020","journal-title":"Cell Metab"},{"issue":"9","key":"10.1016\/bs.pmbts.2022.06.031_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101522","article-title":"Asperuloside improves obesity and type 2 diabetes through modulation of gut microbiota and metabolic signaling","volume":"23","author":"Nakamura","year":"2020","journal-title":"iScience"},{"issue":"2","key":"10.1016\/bs.pmbts.2022.06.031_bb0495","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809302","article-title":"The role of the microbiome in NAFLD and NASH","volume":"11","author":"Kolodziejczyk","year":"2019","journal-title":"EMBO Mol Med"},{"issue":"5","key":"10.1016\/bs.pmbts.2022.06.031_bb0500","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41574-019-0156-z","article-title":"Gut microbial metabolites in obesity, NAFLD and T2DM","volume":"15","author":"Canfora","year":"2019","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10.1016\/bs.pmbts.2022.06.031_bb0505","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.031_bb0510","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-0032-1306423","article-title":"Dyslipidemia in patients with nonalcoholic fatty liver disease","volume":"32","author":"Chatrath","year":"2012","journal-title":"Semin Liver Dis"},{"issue":"5","key":"10.1016\/bs.pmbts.2022.06.031_bb0515","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/nu5051544","article-title":"Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease","volume":"5","author":"Gaggini","year":"2013","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/bs.pmbts.2022.06.031_bb0520","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/bs.pmbts.2022.06.031_bb0525","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/bs.pmbts.2022.06.031_bb0530","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/hep.24268","article-title":"Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver-related mortality","volume":"53","author":"Younossi","year":"2011","journal-title":"Hepatology"},{"issue":"42","key":"10.1016\/bs.pmbts.2022.06.031_bb0535","doi-asserted-by":"crossref","first-page":"15539","DOI":"10.3748\/wjg.v20.i42.15539","article-title":"Histopathology of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"20","author":"Takahashi","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"12","key":"10.1016\/bs.pmbts.2022.06.031_bb0540","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1136\/gutjnl-2012-303816","article-title":"Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice","volume":"62","author":"Le Roy","year":"2013","journal-title":"Gut"},{"issue":"7384","key":"10.1016\/bs.pmbts.2022.06.031_bb0545","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Henao-Mejia","year":"2012","journal-title":"Nature"},{"issue":"7","key":"10.1016\/bs.pmbts.2022.06.031_bb0550","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41591-018-0061-3","article-title":"Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women","volume":"24","author":"Hoyles","year":"2018","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/bs.pmbts.2022.06.031_bb0555","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1499-3872(17)60019-5","article-title":"Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease","volume":"16","author":"Shen","year":"2017","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"7","key":"10.1016\/bs.pmbts.2022.06.031_bb0560","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.cgh.2013.02.015","article-title":"Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease","volume":"11","author":"Raman","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/bs.pmbts.2022.06.031_bb0565","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cmet.2017.04.001","article-title":"Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease","volume":"25","author":"Loomba","year":"2017","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/bs.pmbts.2022.06.031_bb0570","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH","volume":"57","author":"Zhu","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/bs.pmbts.2022.06.031_bb0575","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/bs.pmbts.2022.06.031_bb0580","doi-asserted-by":"crossref","first-page":"32002","DOI":"10.1038\/srep32002","article-title":"Altered fecal microbiota correlates with liver biochemistry in nonobese patients with non-alcoholic fatty liver disease","volume":"23","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/bs.pmbts.2022.06.031_bb0585","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/hep.28572","article-title":"Gut microbiota profiling of pediatricnonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach","volume":"65","author":"Del Chierico","year":"2017","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/bs.pmbts.2022.06.031_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109641","article-title":"Myricetin supplementation decreases hepatic lipid synthesis and inflammation by modulating gut microbiota","volume":"36","author":"Sun","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/bs.pmbts.2022.06.031_bb0595","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/693083","article-title":"Diverse roles of macrophages in atherosclerosis: From inflammatory biology to biomarker discovery","volume":"2012","author":"Gui","year":"2012","journal-title":"Mediators Inflamm"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.031_bb0600","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41467-017-00900-1","article-title":"The gut microbiome in atherosclerotic cardiovascular disease","volume":"8","author":"Jie","year":"2017","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/bs.pmbts.2022.06.031_bb0605","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3389\/fphar.2018.01082","article-title":"The role of gut microbiota in atherosclerosis and hypertension","volume":"25","author":"Ma","year":"2018","journal-title":"Front Pharmacol"},{"issue":"12","key":"10.1016\/bs.pmbts.2022.06.031_bb0610","first-page":"77","article-title":"The role of the gut microbiota in coronary heart disease","volume":"22","author":"Liu","year":"2020","journal-title":"CurrAtheroscler Rep"},{"key":"10.1016\/bs.pmbts.2022.06.031_bb0615","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ncomms2266","article-title":"Symptomatic atherosclerosis is associated with an altered gut metagenome","volume":"3","author":"Karlsson","year":"2012","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.031_bb0620","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00380-016-0841-y","article-title":"Characterization of gut microbiota profiles in coronary artery disease patients using data mining analysis of terminal restriction fragment length polymorphism: Gut microbiota could be a diagnostic marker of coronary artery disease","volume":"32","author":"Emoto","year":"2017","journal-title":"Heart Vessels"},{"issue":"8","key":"10.1016\/bs.pmbts.2022.06.031_bb0625","first-page":"908","article-title":"Analysis of gut microbiota in coronary artery disease patients: A possible link between gut microbiota and coronary artery disease","volume":"23","author":"Emoto","year":"2016","journal-title":"J AtherosclerThromb"},{"issue":"4","key":"10.1016\/bs.pmbts.2022.06.031_bb0630","article-title":"The gut microbiome and cardiovascular disease","volume":"13","author":"Astudillo","year":"2021","journal-title":"Cureus"},{"issue":"22","key":"10.1016\/bs.pmbts.2022.06.031_bb0635","doi-asserted-by":"crossref","first-page":"8729","DOI":"10.3390\/ijms21228729","article-title":"Mutual interplay of host immune system and gut microbiota in the immunopathology of atherosclerosis","volume":"21","author":"Yeh","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"15","key":"10.1016\/bs.pmbts.2022.06.031_bb0640","doi-asserted-by":"crossref","first-page":"8074","DOI":"10.3390\/ijms22158074","article-title":"The role of gut microbiota on cholesterol metabolism in atherosclerosis","volume":"22","author":"Vourakis","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.031_bb0645","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2021.1936379","article-title":"Gut microbiome and its meta-omics perspectives: Profound implications for cardiovascular diseases","volume":"13","author":"Xu","year":"2021","journal-title":"Gut Microbes"},{"issue":"3","key":"10.1016\/bs.pmbts.2022.06.031_bb0650","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3390\/molecules25030594","article-title":"Gut microbiota and its metabolites in atherosclerosis development","volume":"25","author":"Pieczynska","year":"2020","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/bs.pmbts.2022.06.031_bb0655","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/CIRCHEARTFAILURE.113.000978","article-title":"Probiotic administration attenuates myocardial hypertrophy and heart failure after myocardial infarction in the rat","volume":"7","author":"Gan","year":"2014","journal-title":"Circ Heart Fail"},{"issue":"10","key":"10.1016\/bs.pmbts.2022.06.031_bb0660","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1161\/CIRCULATIONAHA.116.024545","article-title":"High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice","volume":"135","author":"Marques","year":"2017","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/bs.pmbts.2022.06.031_bb0665","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/CIRCRESAHA.120.316242","article-title":"Gut microbiota and cardiovascular disease","volume":"127","author":"Witkowski","year":"2020","journal-title":"Circ Res"},{"issue":"24","key":"10.1016\/bs.pmbts.2022.06.031_bb0670","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1161\/CIRCULATIONAHA.115.019645","article-title":"Akkermansia Muciniphila protects against atherosclerosis by preventing metabolic endotoxemia-induced inflammation in Apoe\u2212\/\u2212 mice","volume":"133","author":"Li","year":"2016","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/bs.pmbts.2022.06.031_bb0675","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201900732","article-title":"Akkermansia muciniphila exerts lipid-lowering and immunomodulatory effects without affecting neointima formation in hyperlipidemic APOE*3-Leiden.CETP mice","volume":"64","author":"Katiraei","year":"2020","journal-title":"Mol Nutr Food Res"},{"issue":"11","key":"10.1016\/bs.pmbts.2022.06.031_bb0680","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/cid\/ciu135","article-title":"Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: A randomized, open-label, controlled pilot study","volume":"58","author":"Youngster","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/bs.pmbts.2022.06.031_bb0685","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s15010-012-0307-9","article-title":"Colonoscopic versus nasogastric fecal transplantation for the treatment of Clostridium difficile infection: A review and pooled analysis","volume":"40","author":"Postigo","year":"2012","journal-title":"Infection"},{"key":"10.1016\/bs.pmbts.2022.06.031_bb0690","first-page":"52154","article-title":"Fecal microbiota transplantation via colonoscopy for recurrent C. difficile infection","volume":"94","author":"Allegretti","year":"2014","journal-title":"J Vis Exp"},{"issue":"2","key":"10.1016\/bs.pmbts.2022.06.031_bb0695","first-page":"240","article-title":"An overview of fecal microbiota transplantation: Techniques, indications, and outcomes","volume":"78","author":"Brandt","year":"2013","journal-title":"GastrointestEndosc"},{"issue":"44","key":"10.1016\/bs.pmbts.2022.06.031_bb0700","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1073\/pnas.0407076101","article-title":"The gut microbiota as an environmental factor that regulates fat storage","volume":"101","author":"B\u00e4ckhed","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/bs.pmbts.2022.06.031_bb0705","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/s41591-021-01399-2","article-title":"Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: A randomized double-blind, placebo-controlled phase 2 trial","volume":"27","author":"Mocanu","year":"2021","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/bs.pmbts.2022.06.031_bb0710","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/nm.4345","article-title":"Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug","volume":"23","author":"Wu","year":"2017","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/bs.pmbts.2022.06.031_bb0715","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1172\/JCI129194","article-title":"The gut microbiome and metabolic syndrome","volume":"129","author":"Dabke","year":"2019","journal-title":"J Clin Invest"},{"issue":"7464","key":"10.1016\/bs.pmbts.2022.06.031_bb0720","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nature12506","article-title":"Richness of human gut microbiome correlates with metabolic markers","volume":"500","author":"Le Chatelier","year":"2013","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2022.06.031_bb0725","first-page":"60","article-title":"NAFLD as a continuum: From obesity to metabolic syndrome and diabetes","volume":"12","author":"Godoy-Matos","year":"2020","journal-title":"DiabetolMetabSyndr"},{"issue":"7452","key":"10.1016\/bs.pmbts.2022.06.031_bb0730","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature12198","article-title":"Gut metagenome in European women with normal, impaired and diabetic glucose control","volume":"498","author":"Karlsson","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.031_bb0735","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41577-019-0198-4","article-title":"The intestinal microbiota fuelling metabolic inflammation","volume":"20","author":"Tilg","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10.1016\/bs.pmbts.2022.06.031_bb0740","article-title":"Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes","volume":"16","author":"Scheithauer","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.031_bb0745","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nm.4236","article-title":"A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice","volume":"23","author":"Plovier","year":"2017","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/bs.pmbts.2022.06.031_bb0750","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1136\/gutjnl-2012-303304","article-title":"Insight into the prebiotic concept: Lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women","volume":"62","author":"Dewulf","year":"2013","journal-title":"Gut"}],"container-title":["Progress in Molecular Biology and Translational Science","Human Microbiome in Health and Disease - Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187711732200093X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187711732200093X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T16:09:45Z","timestamp":1681747785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187711732200093X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9780323997867"],"references-count":149,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2022.06.031","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}